FDA-Inspected Site

US Compounding Inc

4 FDA inspections are on record for US Compounding Inc in Conway, United States.

483· Form 483 issued

Conway, United States · Last updated August 15, 2026

Overview

  • 4 FDA inspections are on record.
  • 4 inspections produced a Form 483.
  • The most recent recorded inspection date is 2019-02-07.

At a glance

Inspections

4

Form 483s

4

EIRs

1

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
23 Jan 2019 – 7 Feb 2019Human Drugs483View 483 →
6 Jul 2016 – 15 Jul 2016Human DrugsWLView 483 →
10 Aug 2015 – 21 Aug 2015Human Drugs483View 483 →
17 Mar 2014 – 27 Mar 2014Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

7 Feb 2019
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by June P Page

7 Feb 2019
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by June P Page

7 Feb 2019
21 CFR 211.166(a)(3)

Valid stability test methods

Cited by June P Page

7 Feb 2019
21 CFR 211.192

Investigations of discrepancies, failures

Cited by June P Page

7 Feb 2019
21 CFR 211.22(a)

Approve or reject components, products

Cited by June P Page

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations4x
21 CFR 211.22(a)Cited across public-safe Form 483 observations3x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations3x
21 CFR 211.42(c)(10)(v)Cited across public-safe Form 483 observations3x
21 CFR 211.165(a)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.42(c)(10)(iii)Cited across public-safe Form 483 observations2x
FDCA 503B(a)(10)Cited across public-safe Form 483 observations2x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(c)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.167(a)Cited across public-safe Form 483 observations1x
21 CFR 211.28(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(i)Cited across public-safe Form 483 observations1x
21 CFR 211.56(a)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.94(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind US Compounding Inc's 4 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat